Internet Archive Scholar

AMLODIPINE RELATED GINGIVAL OVERGROWTH IN A PATIENT WITH ASOCIATED AUTOSOMAL POLYCYSTIC KIDNEY DISEASE

Fidan Bahtiar Ismail, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Horia Traian Dumitriu, Anca Silvia Dumitriu, Gener Ismail, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Department of Nephrology, Urology, Transplant Immunology, Dermatology and Allergology, "Carol Davila" University of Medicine and Pharmacy, Bucharest
2015 Romanian Journal of Stomatology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (272.1 kB)
https://web.archive.org/web/20220203092757/https://rjs.com.ro/articles/2015.1/RJS_2015_1_Art-17.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Background. The paper describes the case of a 62 years non-smoking male patient who was referred to the Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, complaining of gingival overgrowth. The patient's medical history revealed that he suffers from autosomal dominant polycystic kidney disease chronic renal failure and hypertension; the patient was under treatment with amlodipine, a calcium channel blocker for 18 months. Case presentation. The patient underwent
more » ... use-related periodontal therapy and flap surgery in areas where only partial resolution of the gingival overgrowth was obtained after completion of initial phase therapy; amlodipine was not substituted because of medical reasons. Results. We obtained complete resolution of the gingival enlargement, even without any change in the causative drug regimen; the patient was placed in a maintenance program, with regular appointments at 3 months; he successfully managed to maintain periodontal and oral health. Conclusions. If possible, all patients who are about to receive calcium channel blockers, should have a detailed periodontal assessment performed and if any periodontal disease discovered, treated properly. In case of established gingival overgrowth, non-surgical and/or surgical periodontal therapy could induce partial or complete remission of enlargement. Change of medication is also an option.
doi:10.37897/rjs.2015.1.17 fatcat:2bjmtwjqzvg3lpq2xiw54n5mve
DOAJ
Citation

Fidan Bahtiar Ismail, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Horia Traian Dumitriu, Anca Silvia Dumitriu, Gener Ismail, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Department of Periodontology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Department of Nephrology, Urology, Transplant Immunology, Dermatology and Allergology, "Carol Davila" University of Medicine and Pharmacy, Bucharest. "AMLODIPINE RELATED GINGIVAL OVERGROWTH IN A PATIENT WITH ASOCIATED AUTOSOMAL POLYCYSTIC KIDNEY DISEASE." Romanian Journal of Stomatology 61.1 (2015) 91-95